A retrospective study analyzing Predictive biomarkers for response to immunotherapy in patients with deficient DNA mismatch repair metastatic colorectal cancer
Latest Information Update: 23 Feb 2023
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Colorectal cancer
- Focus Biomarker; Therapeutic Use
Most Recent Events
- 23 Feb 2023 New trial record